N-cyclohexyl-N-[2-(4-methyl-1-oxa-4-azoniacyclohex-4-yl)ethyl]methanediimine,4-methylbenzenesulfonic acid

We are N-cyclohexyl-N-[2-(4-methyl-1-oxa-4-azoniacyclohex-4-yl)ethyl]methanediimine,4-methylbenzenesulfonic acid CAS:2491-17-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:N-cyclohexyl-N-[2-(4-methyl-1-oxa-4-azoniacyclohex-4-yl)ethyl]methanediimine,4-methylbenzenesulfonic acid
CAS.NO:2491-17-0
Synonyms:1-Cyclohexyl-3-(2-morpholinoethyl)carbodiimide metho-p-toluenesulfonate;CMCT
Molecular Formula:C21H33N3O4S
Molecular Weight:423.56900
 
Physical and Chemical Properties:
Melting point:115-120oC;
 
Specification:
Appearance:White to yellowish powder
Purity:≥95.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:As a condensation reagent
 

N-cyclohexyl-N-[2-(4-methyl-1-oxa-4-azoniacyclohex-4-yl)ethyl]methanediimine,4-methylbenzenesulfonic acid


Related News: Zhejiang Tianyu Co., Ltd .: It is mainly engaged in the research and development and production of sartan-type APIs and intermediates. It has serialized sartan-type APIs and intermediate products, and has accumulated rich chemical synthesis technology. It has strong technical advantages and Scale advantage.4-amino-2-fluorobenzotrifluoruro CAS:69411-68-3 Ten domestic API leading enterprises of CSPC, Puluo Pharmaceutical, Huahai Pharmaceutical, Chuang Nuo Pharmaceutical, Federal Pharmaceuticals, Zhejiang Pharmaceutical, Yifan Pharmaceutical, Jiangxi Tianxin, Zhejiang Chemical Industry, and Xinhua Pharmaceutical rank among China’s API exporters The top ten in the list.4-(4-chlorophenyl)-N,N-diphenylaniline Dr. John K. Westwick, CEO of Resonant, added “Resonant has created a platform for rapid generation of novel anti-tumor antibody candidates.ethyl (1S,3aR,6aS)-octahydrocyclopenta[c]pyrrole-1-carboxylate hydrochloride In recent years, China’s bulk drug companies have gradually completed the upgrade of the product structure of bulk raw materials to specialty raw materials and intermediates. The industry’s leading companies have further developed the research and development layout of high-barrier generic pharmaceutical raw materials with multiple patents that have not yet expired.Active pharmaceutical ingredients affect the structure and function of the human body. Inactive ingredients in a pharmaceutical may be referred to as “bulk pharmaceutical chemicals (BPCs).”

Related Products
Product Name
5-Bromo-2-chloropyrimidine View Details
4-Hydroxypyridine View Details
4-Hydroxybenzoic acid View Details
(2R)-2-acetamido-4-methylpentanoic acid manufacturer 3-Fluorophenol manufacturer 2-(2-methoxyphenoxy)ethanamine manufacturer 4-Fluoro-3-methylbenzaldehyde manufacturer 1,4-Diiodobutane manufacturer